Deuterium Capital Management, LLC Ikena Oncology, Inc. Transaction History
Deuterium Capital Management, LLC
- $29.5 Million
- Q4 2024
A detailed history of Deuterium Capital Management, LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Deuterium Capital Management, LLC holds 80,579 shares of IKNA stock, worth $112,004. This represents 0.45% of its overall portfolio holdings.
Number of Shares
80,579
Previous 80,579
-0.0%
Holding current value
$112,004
Previous $139,000
5.04%
% of portfolio
0.45%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding IKNA
# of Institutions
55Shares Held
31.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.98 Million1.36% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.69 Million2.87% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.57 Million0.25% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.59MShares$4.98 Million3.65% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.92 Million0.16% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $50.4M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...